Sirio Pharma Eyes Southeast Asia and Korea in Bold Push for Global Growth
Sirio Pharma Co., Ltd., founded in 1993 and listed on the Shenzhen Stock Exchange in 2019, has evolved into a globally recognized contract development and manufacturing organization (CDMO) within the nutraceutical sector. Operating seven automated plants and five R&D centers…